Company intelligence / Profile preview

Cellenion

Lyon, France

Ownership: Private
Employees: ~44
Development stage: Other

Overview

Cellenion develops and sells advanced cell isolation and dispensing platforms, enabling precise single-cell analysis for applications in single-cell omics, cell line development, and personalized medicine. Its cellenONE and associated technologies are widely adopted by research institutes and pharma/biotech for front-end cell handling in genomics and proteomics workflows, but Cellenion does not develop therapeutics or clinical-stage assets itself.

Industry: Non-Drug Biotech

Partnerships

BrukerThermo Fisher Scientific

Beyond the preview

Go deeper on Cellenion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellenion.

Explore the full profile